Introduction of ZELBORAF 240MG TABLET:

Vemurafenib,
sold under the brand name Zelboraf, is a medication used in the treatment of
certain types of cancer. It belongs to the class of drugs known as kinase
inhibitors and specifically targets cancer cells with specific genetic
mutations. Vemurafenib was initially approved by the U.S. Food and Drug
Administration (FDA) in 2011 for the treatment of metastatic melanoma, a type
of skin cancer, with a particular genetic mutation known as BRAF V600E.

Uses of ZELBORAF 240MG TABLET:

The primary use of
vemurafenib (Zelboraf) is for the treatment of unresectable or metastatic
melanoma with the BRAF V600E mutation. Before its introduction, metastatic
melanoma had limited treatment options and poor prognosis. Vemurafenib has
shown significant clinical benefits in patients with this specific genetic
mutation, leading to its approval for this indication.

How to use ZELBORAF 240MG TABLET:

Take this medicine in the dose and duration as advised by your
doctor.